Wordt geladen...
Landiolol for managing atrial fibrillation in intensive care
Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the emergency and critical care setting. Accordingly, landiolol is associated with a significantly reduced risk of arterial hypotension and negative inotro...
Bewaard in:
| Gepubliceerd in: | Eur Heart J Suppl |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909768/ https://ncbi.nlm.nih.gov/pubmed/30188960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux039 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|